Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban.

Authors :: Messori A
Maratea D
Fadda V
Trippoli S
Source :: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2014 Apr; Vol. 70 (4), pp. 505-6. Date of Electronic Publication: 2014 Jan 23.
Publication Year :: 2014

Subjects :: Animals
Humans
Anticoagulants adverse effects
Atrial Fibrillation drug therapy
Intracranial Hemorrhages chemically induced

Full Text Access

Tools